iShares Genomics Immunology and Healthcare ETF Rating $22.64 +0.26 (+1.16%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.76Holdings in IDNA have an aggregate rating of Moderate Buy based on 431 analyst ratings issued in the past year covering 36 companies (73.5% of the portfolio).IDNA Aggregate Price Target$22.64High Prediction$22.64Average Prediction$22.64Low Prediction$22.64Holdings in IDNA have an aggregate price target of $22.64 and a range of $22.64 to $22.64 covering 36 companies (73.5% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 36 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.53%EXELExelixis$33.29-1.2%4.4996 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume5.68%GILDGilead Sciences$92.57+1.6%4.4195 of 5 stars2.67$96.43 4.2%27Insider TradeHigh Trading Volume5.12%INCYIncyte$68.84+2.7%4.7108 of 5 stars2.35$76.29 10.8%20Analyst ForecastHigh Trading Volume4.84%BNTXBioNTech$113.08+1.6%2.027 of 5 stars2.82$140.76 24.5%174.76%RVMDRevolution Medicines$44.06+1.8%4.4832 of 5 stars3.09$65.82 49.4%11Insider Trade4.15%SRPTSarepta Therapeutics$118.97-0.4%4.8184 of 5 stars2.91$178.71 50.2%22Analyst ForecastPositive News3.78%ACLXArcellx$75.54+0.4%2.9744 of 5 stars3.13$105.93 40.2%15Positive NewsHigh Trading Volume3.27%TWSTTwist Bioscience$47.94+9.9%2.5467 of 5 stars2.70$51.90 8.3%10High Trading Volume3.15%MRKMerck & Co., Inc.$98.05-1.5%4.9889 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume3.10%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6604 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume3.05%SWTXSpringWorks Therapeutics$35.59+2.3%1.984 of 5 stars3.00$69.50 95.3%62.45%LGNDLigand Pharmaceuticals$114.64+0.6%4.9822 of 5 stars3.00$147.00 28.2%6Analyst RevisionHigh Trading Volume2.29%BEAMBeam Therapeutics$29.01+8.0%3.4396 of 5 stars2.82$47.67 64.3%11Positive NewsHigh Trading Volume2.25%IOVAIovance Biotherapeutics$7.38+2.2%4.0375 of 5 stars2.89$22.33 202.6%92.20%GERNGeron$3.49-4.6%3.8515 of 5 stars3.09$7.15 104.9%11Short Interest ↓High Trading Volume1.87%DVAXDynavax Technologies$12.72-0.3%4.6456 of 5 stars2.67$22.00 73.0%3News CoveragePositive News1.68%BCRXBioCryst Pharmaceuticals$7.57+2.4%3.7207 of 5 stars2.80$15.60 106.1%5News Coverage1.47%BPMCBlueprint Medicines$90.14+1.4%2.5378 of 5 stars2.65$123.33 36.8%20Insider Trade1.36%NRIXNurix Therapeutics$19.83-1.0%2.5007 of 5 stars2.94$30.35 53.1%17News CoverageHigh Trading Volume1.33%NVAXNovavax$8.70+0.2%3.85 of 5 stars2.33$17.83 105.0%6Positive News1.17%MRNAModerna$39.39-0.4%4.2751 of 5 stars2.14$79.50 101.8%22Analyst DowngradeHigh Trading Volume1.06%CRSPCRISPR Therapeutics$40.72+0.8%2.5497 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume0.92%RCUSArcus Biosciences$15.50+0.3%2.6535 of 5 stars3.00$34.00 119.4%9News CoverageGap DownHigh Trading Volume0.86%IBRXImmunityBio$2.62-1.9%2.1671 of 5 stars3.00$17.38 563.2%3Analyst Forecast0.83%VIRVir Biotechnology$7.34-0.4%2.0047 of 5 stars2.60$36.40 395.9%5High Trading Volume0.69%ABCLAbCellera Biologics$2.85+5.2%1.9861 of 5 stars2.67$8.67 204.1%3News Coverage0.52%ARCTArcturus Therapeutics$15.48+4.3%2.3831 of 5 stars3.14$66.75 331.2%7Analyst ForecastNews Coverage0.46%DNAGinkgo Bioworks$10.08+15.3%0.6398 of 5 stars1.60$4.58 -54.6%5News CoverageGap DownHigh Trading Volume0.43%OABIOmniAb$3.501.2687 of 5 stars3.00$9.00 157.1%40.40%QUREuniQure$16.98+9.8%3.5184 of 5 stars3.00$33.88 99.5%10Analyst Forecast0.38%XNCRXencor$24.13+0.5%4.2284 of 5 stars3.11$36.56 51.5%9High Trading Volume0.36%FDMT4D Molecular Therapeutics$6.31+9.2%2.771 of 5 stars2.73$42.56 574.4%11Analyst ForecastHigh Trading Volume0.35%NTLAIntellia Therapeutics$12.18+0.8%4.2319 of 5 stars2.72$54.94 351.0%18High Trading Volume0.32%CVACCureVac$2.87-4.0%4.5781 of 5 stars2.25$10.00 248.4%4News CoverageGap Down0.23%MGNXMacroGenics$3.183.543 of 5 stars2.36$7.63 139.8%110.20%EDITEditas Medicine$1.31-2.2%4.3935 of 5 stars2.07$7.00 434.4%14High Trading Volume This page (NYSEARCA:IDNA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
